ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy (Q38766657)

6 September 2017

title

ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy (English)

1 reference

6 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28115743%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Y Ivashko-Pachima

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28115743%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

A Malishkevich

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28115743%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

I Gozes

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28115743%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

English

0 references

publication date

24 January 2017

1 reference

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28115743%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28115743%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28115743%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

1335-1344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28115743%20AND%20SRC:MED&resulttype=core&format=json

Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Activity-dependent neuroprotective protein: a novel gene essential for brain formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

The Compassionate Side of Neuroscience: Tony Sermone's Undiagnosed Genetic Journey--ADNP Mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Alterations in Activity-Dependent Neuroprotective Protein in Sporadic and Experimental Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Autophagy has a key role in the pathophysiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

The human SWI/SNF subunit Brm is a regulator of alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Tau regulates the localization and function of End-binding proteins 1 and 3 in developing neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Maturation of neuroblastoma cells in the presence of dimethylsulfoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

GFP chimeras of E-MAP-115 (ensconsin) domains mimic behavior of the endogenous protein in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Meta-Analysis for Genome-Wide Association Study Identifies Multiple Variants at the BIN1 Locus Associated with Late-Onset Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Mammalian end binding proteins control persistent microtubule growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Peptide neuroprotection through specific interaction with brain tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

The microtubule-binding protein ensconsin is an essential cofactor of kinesin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Molecular insights into mammalian end-binding protein heterodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

End binding proteins are obligatory dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Interaction of mammalian end binding proteins with CAP-Gly domains of CLIP-170 and p150(glued)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Ordered recruitment of dynactin to the microtubule plus-end is required for efficient initiation of retrograde axonal transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

The neuroprotective peptide NAP does not directly affect polymerization or dynamics of reconstituted neural microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Effects of Paclitaxel and Eribulin in Mouse Sciatic Nerve: A Microtubule-Based Rationale for the Differential Induction of Chemotherapy-Induced Peripheral Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Addressing Alzheimer's disease tangles: from NAP to AL-108.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

A double-blind, placebo-controlled, ascending-dose, randomized study to evaluate the safety, tolerability and effects on cognition of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

ADNP: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

MAP1B regulates microtubule dynamics by sequestering EB1/3 in the cytosol of developing neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Tau antagonizes end-binding protein tracking at microtubule ends through a phosphorylation-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

A genome-wide association study of bipolar disorder with comorbid eating disorder replicates the SOX2-OT region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Risperidone and NAP protect cognition and normalize gene expression in a schizophrenia mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

+TIPs: SxIPping along microtubule ends

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Control of microtubule organization and dynamics: two ends in the limelight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

Axonal tau mRNA localization coincides with tau protein in living neuronal cells and depends on axonal targeting signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.255

7 January 2021

inferred from DOI database lookup

Expression of tau protein in non-neuronal cells: microtubule binding and stabilization

1 reference

12 December 2020

Cervical smears in the study of intraepithelial neoplasms

1 reference

12 December 2020

Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage

1 reference

12 December 2020

Tau interacts with src-family non-receptor tyrosine kinases

1 reference

12 December 2020

Identifiers

DOI

10.1038/MP.2016.255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28115743%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference